finance

3 major insulin makers have now slashed the price of the life-saving drug. Here's why.


Sanofi on Thursday became the last major insulin maker to cut the price of the life-saving drug. Here’s why it’s been so expensive and what’s next.

     



READ SOURCE

Readers Also Like:  Car-charging and dog hotels: Seven perks to lure you to the office

This website uses cookies. By continuing to use this site, you accept our use of cookies.